PRO045-CLIN-01: A Phase IIb Study of Duchenne Muscular Dystrophy

• Research type

  Research Study

• Full title

  A phase IIb, open-label study to assess the efficacy, safety, pharmacodynamics and pharmacokinetics of multiple doses of PRO045 in subjects with Duchenne muscular dystrophy

• IRAS ID

  117125

• Contact name

  Volker Straub

• Contact email

  volker.straub@newcastle.ac.uk

• Sponsor organisation

  Prosensa Therapeutics BV

• Eudract number

  2011-005040-10

• ISRCTN Number

  N/A

• REC name

  North East - Newcastle & North Tyneside 1 Research Ethics Committee

• REC reference

  13/NE/0050

• Date of REC Opinion

  22 Apr 2013

• REC opinion

  Further Information Favourable Opinion